When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.

Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer

The Continuous Update Project (CUP) is an ongoing program that analyzes global research on how diet, nutrition and physical activity affect cancer risk and survival.

A major milestone in cancer research, the Third Expert Report analyzes and synthesizes the evidence gathered in CUP reports and serves as a vital resource for anyone interested in preventing cancer.

AICR has pushed research to new heights, and has helped thousands of communities better understand the intersection of lifestyle, nutrition, and cancer.

Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.

We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.

AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.

AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.

AICR is committed to putting what we know about cancer prevention into action. To help you live healthier, we’ve taken the latest research and made 10 Cancer Prevention Recommendations.

AICR Leadership

AICR Grant Panel

Scott Bultman, PhD

Scott Bultman, Ph.D., is an Associate Professor with the Department of Genetics and School of Medicine at the University of North Carolina at Chapel Hill. He uses gnotobiotic models to investigate the role of dietary fiber and colorectal cancer and is also using intestinal organoids that more accurately model intestinal crypts.

Andrew T. Chan, MD, MPH

Andrew T. Chan is a Gastroenterologist at Massachusetts General Hospital with clinical interests in cancer prevention, gastroenterology, colon and rectal cancer, hereditary colorectal cancer, and gastrointestinal cancer.

Robert Chapkin, PhD

Robert Chapkin is an Allen Endowed Chair in Nutrition and Chronic Disease Prevention in the Department of Nutrition and Food Science at Texas A&M University. Research in the Chapkin lab focuses on dietary/microbial modulators related to the prevention of cancer and chronic inflammatory diseases.

Linda S. Cook, PhD

Linda Cook is the co-leader of the Cancer Control Research Program at the University of New Mexico Comprehensive Cancer Center. Her areas of research include general cancer epidemiology with a particular focus on identifying ways to reduce the occurrence of, and mortality from, ovarian, endometrial and breast cancer.

Christina Dieli-Conwright, PhD, MPH

Christina Dieli-Conwright , PhD, MPH is an Assistant Professor of Research with the Division of Biokinesiology and Physical Therapy at the Herman Ostrow School of Dentistry at the University of Southern California. She is an expert in exercise oncology, metabolic syndrome and obesity in cancer survivors, cancer health disparities.

Joanne Elena, PhD, MPH

Joanne Elena, Ph.D., M.P.H., is an Epidemiologist and Program Director in the Clinical and Translational Epidemiology Branch of the Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). She is responsible for developing, managing, and promoting a research portfolio of grants focused on diet and lifestyle factors that influence cancer progression, recurrence and survival, and the development of second primary cancers.

Heather Eliassen, ScD

Heather Eliassen, ScD is an Associate Professor in the Department of Epidemiology at Harvard T.H. Chan School of Public Health at Harvard University. Dr. Eliassen conducts research focusing on the etiology of breast cancer, examining associations between lifestyle factors, biomarkers of lifestyle and hormones, and breast cancer risk.

James Fleet, PhD

James Fleet, Ph.D., is a faculty member at Purdue University with the Department of Nutrition Science whose laboratory is focused on two major themes: (1) the molecular regulation and genetics of bone and mineral metabolism, (2) mechanisms of carcinogenesis and cancer prevention. Many, but not all, of their projects revolve around the role of vitamin D in health.

Terryl Hartman, PhD, MPH, RD

Terryl Hartman, PhD, MPH, RD, is a Professor of Epidemiology in the Department of Epidemiology at Rollins School of Public Health, Emory University. Her research is focused on the role of diet and nutrition in the etiology and prevention of chronic diseases—especially cancer—and the development and application of improved dietary assessment methods in chronic disease research.

Rishi Jain, MD

Rishi Jain, M.D., is a medical oncologist specializing in cancers of the gastrointestinal tract at Fox Chase Cancer Center. His research focus is related to the intersections between diet, nutrition, physical activity, and cancer therapy, and he specializes in Colorectal Cancer, Esophageal Cancer, Liver, Gall Bladder, and Bile Duct Cancer, Neuroendocrine Tumors, Pancreatic Cancer, and Stomach Cancer.

Johanna Lampe, PhD, RD

Johanna Lampe, PhD, RD, is an experimental nutritionist and cancer prevention researcher at the Fred Hutchinson Cancer Research Center. She studies how one’s diet, particularly the consumption of plant foods, affects cancer risk. Her work includes using nutrition-intervention studies to investigate differences in how people respond to various foods and using such feeding studies to search for biomarkers, or molecular signals, of dietary exposure.

 

Fayth Miles, PhD

Fayth Miles, PhD is an investigator in the Loma Linda University School of Public Health with a secondary appointment in the School of Medicine. She is conducting research examining the interplay of lifestyle factors with alterations in biomarkers in the Adventist Health Study-2 cohort and examining the association of diet patterns with metabolic and epigenetic signatures using omics data to uncover novel mechanisms for diet-disease relationships.

Erik Nelson, PhD

Erik Nelson, Ph.D., is an assistant professor of molecular and integrative physiology in the School of Molecular and Cellular Biology at the University of Illinois at Urbana-Champaign. His research focuses on how endocrine and metabolic factors impact the progression of breast and ovarian cancers.

Kimberly Robien, PhD, RD, CSO, FAND

Kimberly Robien, PhD, RD, CSO, FAND is a nutrition scientist and cancer epidemiologist at George Washington University Milken Institute of Public Health whose research focuses on diet and body composition in relation to cancer prevention and survivorship. She is also a member of the GW Cancer Center, and a fellow with the Sumner M. Redstone Global Center for Prevention and Wellness.

Daniel Rosenberg, PhD

Daniel Rosenberg, PhD, is a Professor of Medicine andHealth Net Inc. Endowed Chair in Cancer Biology; Investigator at the Center for Molecular Oncology at UConn Health. His laboratory has a longstanding interest in the molecular events that accompany early gastrointestinal neoplasia. A major effort of their laboratory is to develop natural products that may be used to interrupt the processes of cancer initiation and progression.

Kenneth Schwartz, MD

Kenneth Schwartz, M.D., is a Professor Emeritus in the department of medicine at Michigan State University. He has an interest in hematology, oncology and internal medicine.

Paul Spagnuolo, PhD

Paul Spagnuolo  PhD, is an Associate Professor in the Department of Food Science at the University of Guelph. His research focuses on the development of nutraceuticals as novel therapeutics and understanding cellular mechanisms by which nutraceuticals influence cell biology.

Close